Gene Therapy for Chronic Granulomatous Disease in Korea

Summary

The purpose of this study is to evaluate the safety and efficacy of administration of autologous hematopoietic stem cells transduced with MT-gp91 retroviral vector for patients with X-linked chronic granulomatous disease.

Timeline

Start

2007-01

Primary completion

2008-10

Completion

2010-10

Outcome

Outcome not reported

Stopped: “This Korean Phase 1 study was Withdrawn more than 15 years ago and no data is available.”

Drugs

Indications